32.035 USD
+0.64 (+2.05%)
Taking everything into account, AXGN scores 5 out of 10 in our fundamental rating. AXGN was compared to 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of AXGN get a neutral evaluation. Nothing too spectacular is happening here. AXGN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
AXGN had positive earnings in the past year.
In the past year AXGN had a positive cash flow from operations.
AXGN had negative earnings in each of the past 5 years.
AXGN had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
AXGN has a better Return On Assets (-0.97%) than 72.19% of its industry peers.
AXGN has a better Return On Equity (-1.74%) than 72.19% of its industry peers.
AXGN has a better Return On Invested Capital (1.65%) than 67.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.97% | ||
| ROE | -1.74% | ||
| ROIC | 1.65% |
ROA(3y)-10.24%
ROA(5y)-11.1%
ROE(3y)-20.3%
ROE(5y)-20.84%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 1.84%, AXGN is in the better half of the industry, outperforming 67.38% of the companies in the same industry.
Looking at the Gross Margin, with a value of 74.76%, AXGN belongs to the top of the industry, outperforming 84.49% of the companies in the same industry.
AXGN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.84% | ||
| PM (TTM) | N/A | ||
| GM | 74.76% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5Y-1.5%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AXGN is destroying value.
The number of shares outstanding for AXGN has been increased compared to 1 year ago.
AXGN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AXGN has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 8.72 indicates that AXGN is not in any danger for bankruptcy at the moment.
AXGN has a better Altman-Z score (8.72) than 88.24% of its industry peers.
AXGN has a debt to FCF ratio of 23.40. This is a negative value and a sign of low solvency as AXGN would need 23.40 years to pay back of all of its debts.
AXGN has a Debt to FCF ratio of 23.40. This is in the better half of the industry: AXGN outperforms 69.52% of its industry peers.
AXGN has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
AXGN's Debt to Equity ratio of 0.40 is in line compared to the rest of the industry. AXGN outperforms 46.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | 23.4 | ||
| Altman-Z | 8.72 |
ROIC/WACC0.19
WACC8.9%
2.3 Liquidity
AXGN has a Current Ratio of 4.09. This indicates that AXGN is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 4.09, AXGN is doing good in the industry, outperforming 69.52% of the companies in the same industry.
A Quick Ratio of 2.64 indicates that AXGN has no problem at all paying its short term obligations.
AXGN's Quick ratio of 2.64 is fine compared to the rest of the industry. AXGN outperforms 61.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.09 | ||
| Quick Ratio | 2.64 |
3. Growth
3.1 Past
AXGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2089670227099910400.00%, which is quite impressive.
AXGN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.72%.
Measured over the past years, AXGN shows a quite strong growth in Revenue. The Revenue has been growing by 11.92% on average per year.
EPS 1Y (TTM)2089670227099910400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.43%
Revenue 1Y (TTM)18.72%
Revenue growth 3Y13.72%
Revenue growth 5Y11.92%
Sales Q2Q%23.51%
3.2 Future
The Earnings Per Share is expected to grow by 53.04% on average over the next years. This is a very strong growth
AXGN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.92% yearly.
EPS Next Y126.75%
EPS Next 2Y94.47%
EPS Next 3Y81.44%
EPS Next 5Y53.04%
Revenue Next Year19.74%
Revenue Next 2Y17.75%
Revenue Next 3Y17.45%
Revenue Next 5Y15.92%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 110.47, AXGN can be considered very expensive at the moment.
AXGN's Price/Earnings ratio is a bit cheaper when compared to the industry. AXGN is cheaper than 65.24% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.22, AXGN is valued quite expensively.
The Price/Forward Earnings ratio is 65.16, which means the current valuation is very expensive for AXGN.
AXGN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AXGN is cheaper than 67.91% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.58, AXGN is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 110.47 | ||
| Fwd PE | 65.16 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AXGN is valued a bit cheaper than 64.17% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AXGN is valued a bit cheaper than 67.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 717.21 | ||
| EV/EBITDA | 144.82 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AXGN's earnings are expected to grow with 81.44% in the coming years.
PEG (NY)0.87
PEG (5Y)N/A
EPS Next 2Y94.47%
EPS Next 3Y81.44%
5. Dividend
5.1 Amount
AXGN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:AXGN (12/18/2025, 11:39:53 AM)
32.035
+0.64 (+2.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners91.23%
Inst Owner Change1.96%
Ins Owners1.47%
Ins Owner Change0.33%
Market Cap1.48B
Revenue(TTM)214.71M
Net Income(TTM)-2.10M
Analysts84
Price Target34.58 (7.94%)
Short Float %6.51%
Short Ratio3.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)74.96%
Min EPS beat(2)64.15%
Max EPS beat(2)85.77%
EPS beat(4)3
Avg EPS beat(4)10.46%
Min EPS beat(4)-222.55%
Max EPS beat(4)114.46%
EPS beat(8)7
Avg EPS beat(8)179.5%
EPS beat(12)11
Avg EPS beat(12)144.63%
EPS beat(16)14
Avg EPS beat(16)118.71%
Revenue beat(2)2
Avg Revenue beat(2)4.58%
Min Revenue beat(2)3.69%
Max Revenue beat(2)5.47%
Revenue beat(4)2
Avg Revenue beat(4)1.85%
Min Revenue beat(4)-1.48%
Max Revenue beat(4)5.47%
Revenue beat(8)5
Avg Revenue beat(8)1.84%
Revenue beat(12)7
Avg Revenue beat(12)0.83%
Revenue beat(16)8
Avg Revenue beat(16)0.37%
PT rev (1m)36.21%
PT rev (3m)36.28%
EPS NQ rev (1m)0.19%
EPS NQ rev (3m)-12.78%
EPS NY rev (1m)-1.7%
EPS NY rev (3m)13.33%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 110.47 | ||
| Fwd PE | 65.16 | ||
| P/S | 6.88 | ||
| P/FCF | 717.21 | ||
| P/OCF | 226.99 | ||
| P/B | 12.23 | ||
| P/tB | 12.92 | ||
| EV/EBITDA | 144.82 |
EPS(TTM)0.29
EY0.91%
EPS(NY)0.49
Fwd EY1.53%
FCF(TTM)0.04
FCFY0.14%
OCF(TTM)0.14
OCFY0.44%
SpS4.66
BVpS2.62
TBVpS2.48
PEG (NY)0.87
PEG (5Y)N/A
Graham Number4.13
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.97% | ||
| ROE | -1.74% | ||
| ROCE | 2.09% | ||
| ROIC | 1.65% | ||
| ROICexc | 2.04% | ||
| ROICexgc | 2.13% | ||
| OM | 1.84% | ||
| PM (TTM) | N/A | ||
| GM | 74.76% | ||
| FCFM | 0.96% |
ROA(3y)-10.24%
ROA(5y)-11.1%
ROE(3y)-20.3%
ROE(5y)-20.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5Y-1.5%
F-Score6
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | 23.4 | ||
| Debt/EBITDA | 4.82 | ||
| Cap/Depr | 73.42% | ||
| Cap/Sales | 2.07% | ||
| Interest Coverage | 0.59 | ||
| Cash Conversion | 65.09% | ||
| Profit Quality | N/A | ||
| Current Ratio | 4.09 | ||
| Quick Ratio | 2.64 | ||
| Altman-Z | 8.72 |
F-Score6
WACC8.9%
ROIC/WACC0.19
Cap/Depr(3y)361.61%
Cap/Depr(5y)683.78%
Cap/Sales(3y)9.04%
Cap/Sales(5y)13.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2089670227099910400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.43%
EPS Next Y126.75%
EPS Next 2Y94.47%
EPS Next 3Y81.44%
EPS Next 5Y53.04%
Revenue 1Y (TTM)18.72%
Revenue growth 3Y13.72%
Revenue growth 5Y11.92%
Sales Q2Q%23.51%
Revenue Next Year19.74%
Revenue Next 2Y17.75%
Revenue Next 3Y17.45%
Revenue Next 5Y15.92%
EBIT growth 1Y146.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1581.81%
EBIT Next 3Y218.48%
EBIT Next 5YN/A
FCF growth 1Y108.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y256.84%
OCF growth 3YN/A
OCF growth 5YN/A
AXOGEN INC / AXGN FAQ
What is the fundamental rating for AXGN stock?
ChartMill assigns a fundamental rating of 5 / 10 to AXGN.
What is the valuation status of AXOGEN INC (AXGN) stock?
ChartMill assigns a valuation rating of 4 / 10 to AXOGEN INC (AXGN). This can be considered as Fairly Valued.
How profitable is AXOGEN INC (AXGN) stock?
AXOGEN INC (AXGN) has a profitability rating of 4 / 10.
Can you provide the financial health for AXGN stock?
The financial health rating of AXOGEN INC (AXGN) is 6 / 10.
Can you provide the expected EPS growth for AXGN stock?
The Earnings per Share (EPS) of AXOGEN INC (AXGN) is expected to grow by 126.75% in the next year.